A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This trial is a multi-center, open-label, dose-escalation study designed to evaluate the
safety, tolerability and pharmacokinetics of Cethrin in two types of spinal cord injury
patients: those with a complete cervical injury or a complete thoracic injury. Dose levels
from 0.3 mg - 9 mg of Cethrin will be administered.